The table below shows RESMED INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$5.15B
$4.69B
$4.22B
$3.58B
$3.20B
$2.96B
Cost of revenue
$2.09B
$2.03B
$1.87B
$1.55B
$1.36B
$1.24B
Gross profit
$3.05B
$2.66B
$2.36B
$2.02B
$1.84B
$1.72B
R&D
$331.28M
$307.52M
$287.64M
$253.57M
$225.28M
$201.95M
SG&A
RMD annual revenue (10-K history)
RESMED INC reported annual revenue of $5.15B for fiscal year 2025. That is up 9.8% from $4.69B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.84B (FY 2016) to $5.15B. Figures come from the company's audited annual reports as filed with the SEC.
